Ajuste direto para aquisição de RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] e RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA]

ID 12698054 · Portal BASE
Price
Base Price
€597,008 .00
Effective Price
€7,243 .00 -98.8%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Vila Franca de Xira
Bidder Count
—
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Company
Dates
Publication
20 Jan 2026
Celebration
12 Jan 2026
Contracting Entity
Unidade Local de Saúde do Estuário do Tejo, E. P. E.
NIF 516487493
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
597008.0
Total effective price
7243.0
Ratio
0.0121
Direction
reduction
Rule
A9 price reduction: ratio 0.0121 outside [0.5, 1.5]
Detected 2026-03-06